Sequential Dose-Dense Doxorubicin and Ifosfamide in Advanced Soft-Tissue Sarcoma Patients in an Out-Patient-Basis Schedule

Aims. This phase II study explored activity/safety of front-line dose-dense chemotherapy in high-grade STS (soft tissue sarcoma) patients and tested ezrin as prognostic factor. Patients and Methods. The protocol consisted of three cycles of doxorubicin (DOXO) 30 mg/m(2) on days 1–3 every 2 weeks, fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Almeida, G. F. G., Castro, G., Snitcovsky, I. M. L., Siqueira, S. A., Akaishi, E. H., Camargo, O. P., Oliveira, C. R. G. C. M., Federico, M. H. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140044/
https://www.ncbi.nlm.nih.gov/pubmed/21785570
http://dx.doi.org/10.1155/2011/984340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140044/
https://www.ncbi.nlm.nih.gov/pubmed/21785570
http://dx.doi.org/10.1155/2011/984340

Ejemplares similares